Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Urged To Drop Snail Mail For IND Communications
Aug 13 2020
•
By
Derrick Gingery
Industry representatives said the FDA should rely on email for formal communications and stop using snail mail. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA
More from Agency Leadership